Dokumen

Perbincangan Teknikal Ramalan Bermusim Opsyen

Pemfailan SEC dan dokumen lain LAVA Therapeutics N.V.

Terokai dokumen syarikat terkini dan pemfailan SEC dari LAVA Therapeutics N.V., termasuk Forms 10-K, 10-Q, 8-K dan pendedahan utama lain. Nilaikan prestasi kewangan dan kemas kini pengoperasian untuk melakukan keputusan lebih termaklum.

Rakan kongsi data

Huraian

Reported date

Borang

2025

Q2 2025

Ogos 13, 2025

Earnings release8-K

Quarterly report10-Q

Q1 2025

Mei 13, 2025

Earnings release8-K

Quarterly report10-Q

2024

Q4 2024

Mac 28, 2025

Annual report10-K

Earnings release8-K

Q3 2024

Dis 10, 2024

Earnings release8-K

Q2 2024

Ogos 20, 2024

Earnings release8-K

Q1 2024

Mei 21, 2024

Earnings release8-K

2023

Q4 2023

Mac 20, 2024

Annual report20-F

Earnings release8-K

Q3 2023

Nov 16, 2023

Earnings release8-K

Q2 2023

Ogos 22, 2023

Earnings release8-K

Q1 2023

Jun 07, 2023

Earnings release8-K

2022

Q4 2022

Apr 11, 2023

Annual report20-F

Earnings release8-K

Q3 2022

Nov 16, 2022

Earnings release8-K

Q2 2022

Sep 13, 2022

Earnings release8-K

Study Update

Jun 16, 2022

Press release

Q1 2022

Mei 17, 2022

Earnings release8-K

2021

Q4 2021

Mac 24, 2022

Annual report20-F

Earnings release8-K

Q3 2021

Nov 15, 2021

Earnings release8-K

Q2 2021

Ogos 16, 2021

Earnings release8-K

Q1 2021

Mei 20, 2021

Earnings release8-K